Shalini Sharp
2013 - Ultragenyx Pharmaceutical
In 2013, Shalini Sharp earned a total compensation of $625.2K as Chief Financial Officer and Senior Vice President at Ultragenyx Pharmaceutical, a 106% increase compared to previous year.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Non-Equity Incentive Plan | $110,206 |
| Option Awards | $182,394 |
| Salary | $278,440 |
| Other | $24,193 |
| Total | $625,233 |
Sharp received $278.4K in salary, accounting for 45% of the total pay in 2013.
Sharp also received $30K in bonus, $110.2K in non-equity incentive plan, $182.4K in option awards and $24.2K in other compensation.
Rankings
In 2013, Shalini Sharp's compensation ranked 8,578th out of 12,286 executives tracked by ExecPay. In other words, Sharp earned more than 30.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,578 out of 12,286 | 30th |
Division Manufacturing | 3,116 out of 4,612 | 32nd |
Major group Chemicals And Allied Products | 983 out of 1,466 | 33rd |
Industry group Drugs | 748 out of 1,160 | 36th |
Industry Pharmaceutical Preparations | 590 out of 890 | 34th |
Source: SEC filing on April 18, 2016.
Sharp's colleagues
We found two more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2013.